How Secure are Your UV/Vis Electronic Records? Ensure Data Integrity Compliance with these 7 Solutions
Oct 03 2018 Read 1554 Times
Are you worried about FDA warning letters? In 2016, 80% of the FDA warning letters issued were due to lack of data integrity. The primary reason was incomplete data. This problem can be prevented with the right solutions.
The completeness, security and accuracy of your UV/VIS electronic records are essential in fulfilling the FDA 21 CFR Part 11 guidelines concerning data integrity. A combination of using efficient, secure software to store your records, along with implementing Good UV/VIS Practice removes the risk of such warning letters. METTLER TOLEDO offers a comprehensive solution to all elements of these guidelines in the form of LabX PC software. By following sample analysis SOPs, providing secure SQL database storage, supporting e-signatures, and requesting user authentication for authorized data access, LabX streamlines the process of compliance into one straightforward solution.
Does your current UV/VIS system comply with data integrity requirements? Download our infographic to get the 7 key answers to data integrity for UV/VIS workflows. These topics form the foundation for a well-rounded and compliant solution to achieve optimal data integrity.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In this edition Articles - Detection of molecular markers in aquatic sediments by ion profi les obtained by GC/MS system - Fighting the Resistance: How Rapid Microbial ID with MALDI MS and A...
View all digital editions
Feb 20 2019 Mumbai, India
Feb 21 2019 New Delhi, India
Feb 25 2019 Moscow, Russia
Feb 26 2019 Guangzhou, China
Feb 27 2019 Berlin, Germany